Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 2—Errors of Inexact Identification and Inaccurate Quantitation

References

1. 1.↵
   U.S. Food and Drug Administration. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services: Rockville, MD, 1999.

   Google Scholar
2. 2.↵
   European Medicines Agency. Guideline on Plastic Immediate Packaging Materials. EMA: London, 2005.

   Google Scholar
3. 3.↵
   1. Jenke D.

   Material Screening and Characterization. In Compatibility of Pharmaceutical Products and Contact Materials: Safety Considerations Associated with Extractables and Leachables; John Wiley and Sons: Hoboken, NY, 2009; Chapter 4, pp 124–131.

   Google Scholar
4. 4.↵
   1. Ball D. J.,
   2. Norwood D. L.,
   3. Stults C. L. M.,
   4. Nagao L. M.

   1. Norwood D. L.,
   2. Feinberg T. N.,
   3. Mullis J. O.,
   4. Pennino C. J.

   Analytical Techniques for Identification and Quantitation of Extractables and Leachables. In Leachables and Extractables Handbook: Safety Evaluation, Qualification and Best Practices Applied to Inhalation Drug Products; Ball D. J., Norwood D. L., Stults C. L. M., Nagao L. M., Eds.; John Wiley and Sons: Hoboken, NY, 2012; Chapter 13, pp 241–288.

   Google Scholar
5. 5.↵
   U.S. Pharmacopeial Convention. General Chapter <1663> Assessment of Extractables Associated with Pharmaceutical Packaging/Delivery Systems. In USP 41–NF 36; USP: Rockville, MD, 2018; p 7910.

   Google Scholar
6. 6.↵
   1. Christiaens P.,
   2. Beusen J. M.,
   3. Verlinde P.,
   4. Baeten J.,
   5. Jenke D.

   Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1: Introduction to Errors in Chromatographic Screening for Organic Extractables & Leachables and Discussion of the Error of Omission. PDA J. Pharm. Sci. Technol. 2020, 74 (1), 90–107.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
7. 7.↵
   U.S. Environmental Protection Agency. Method 8260D (SW-846): Volatile Organic Compounds by Gas Chromatography/Mass Spectrometry (GC/MS). EPA: Washington, DC, 2018; Revision 4.

   Google Scholar
8. 8.↵
   U.S. Environmental Protection Agency. Method 8270E (SW-846): Semivolatile Organic Compounds by Gas Chromatography/Mass Spectrometry (GC/MS). EPA: Washington, DC, 2018; Revision 6.

   Google Scholar
9. 9.↵
   Wiley Registry 11th Edition/NIST 2017 Mass Spectral Library; Wiley, NIST, 2017.

   Google Scholar
10. 10.↵
    1. Mullis J. O.,
    2. Granger A.,
    3. Quin C.,
    4. Norwood D. L.

    The Analytical Evaluation Threshold (AET) Concept, Sensitivity and Analytical Uncertainty. Presented at Leachables and Extractables 2008, Dublin, Ireland, Mar 5–6, 2008.

    Google Scholar
11. 11.↵
    1. Jenke D.,
    2. Odufu A.

    Utilization of Internal Standard Response Factors to Estimate the Concentration of Organic Compounds Leached from Pharmaceutical Packaging Systems and Application of Such Estimated Concentrations to Safety Assessment. J. Chromatogr. Sci. 2012, 50 (3), 206–212.

    OpenUrlCrossRefPubMedGoogle Scholar
12. 12.↵
    1. Zdravkovic S. A.,
    2. Duong C. T.,
    3. Hellenbrand A. A.,
    4. Duff S. R.,
    5. Dreger A. L.

    Establishment of a Reference Standard Database for Use in the Qualitative and Semi-Quantitative Analysis of Pharmaceutical Contact Materials Within a Extractables Survey by GC-MS. J. Pharm. Biomed. Anal. 2018, 151, 49–60.

    OpenUrlGoogle Scholar
13. 13.↵
    1. Jenke D.,
    2. Liu N.

    Chromatographic Considerations in the Standardization of Liquid Chromatographic Methods Used for Extractables Screening. J. Liq. Chromatogr. Relat. Technol. 2016, 39 (13), 613–619.

    OpenUrlGoogle Scholar
14. 14.↵
    1. Jordi M. A.,
    2. Khera S.,
    3. Roland K.,
    4. Jiang L.,
    5. Solomon P.,
    6. Nelson J.,
    7. Lateef S. S.,
    8. Woods J.,
    9. Martin L.,
    10. Martin S.,
    11. Aiello F.,
    12. Chen N.

    Qualitative Assessment of Extractables Form Single-Use Components and the Impact of Reference Standard Selection. J. Pharm. Biomed. Anal. 2018, 150, 368–376.

    OpenUrlGoogle Scholar